BLOCKStrain Addresses Cannabis Diversion & Inversion Challenges
Ryan Allway
October 29th, 2018
News, Top News
The U.S. cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. At the same time, Deloitte believes Canada’s cannabis industry will reach C$22.6 billion within five years following the legalization of recreational cannabis on a national level—a move that made it the first G7 nation to address the problem.
In this article, we will take a look at some of the challenges facing consumers, businesses, and regulators within the cannabis industry and how companies like BLOCKStrain Technology Corp. (TSX-V: DNAX) (OTC: BKKSF) aim to address the issues head-on using innovative new technology.
Diversion vs. Inversion Issues
Lawmakers across North America are calling for strict regulatory oversight to prevent diversion—or the transfer of legal cannabis to the black market. Overproduction and high tax rates have encouraged some cultivators in the United States to risk their licenses and sell excess cannabis into the black market to recoup costs or generate excess profits. These activities not only enrich criminal enterprises, but could damage the industry’s credibility.
In Canada regulators have seen producers licensed under the Medical Marijuana Access Regulations abusing their license to produce very small amounts of cannabis, and instead produce massive quantities of cannabis and extracts bound for the black market.
For example, a medical cannabis grow operation was recently shut down near Toronto after it was discovered that personal medical marijuana licenses were being used to grow $6.5 million in illegal plants across 22 industrial greenhouses. These kinds of industrial-scale personal grows have become magnets for theft and violence, with a number of homicides linked to what would normally be considered legal businesses.
Inversion—or the sale of black market product in the legal market—has become an equally concerning problem. Black market product is untested and could contain pesticides, heavy metals, and other contaminants. Consumers that unknowingly purchase black market cannabis could be taking on significant health risks. Over time, these problems could lead to a crisis of confidence in the industry on the part of consumers.
How Seed-to-Sale Tracking Helps
Seed-to-sale tracking solutions can help address both diversion and inversion problems facing the legal cannabis industry. Under these schemes, individual plants are tagged with barcodes or identification tags that are used to track them through the supply chain. The closed-loop system helps prevent diversion from occurring, since regulators can easily check and see whether yields are abnormally low given a certain number of plants.
BLOCKStrain Technology Corp. (TSX-V: DNAX) (OTC: BKKSF) goes one step further with Genome-to-Sale™ tracking powered by an immutable blockchain-powered ledger. By utilizing a genetic based identification system and placing that information into a unique barcode, cannabis consumers, businesses, regulators, and even other software companies can quickly determine everything from potential contamination to the potency of each strain. Strain breeders at Licensed Producers can also ensure their intellectual property is protected when licensing strains.
The company began by partnering with licensed testing facilities and streamlining the lab process to reduce red tape. For each batch of products processed, a blockchain transaction is created, thus becoming a unique identifier that is used throughout the supply chain. Craft growers use the platform to protect the intellectual property of their unique strains, and now, licensed producers like WeedMD Inc. (TSX-V: WMD) have entered the fold.
Looking Ahead
Inversion and diversion are enormous problems facing the North American cannabis industry. If they’re not addressed, it could lead regulators to crack down on legal cannabis programs in the United States and hurt consumer confidence in product quality.
BLOCKStrain Technology Corp. (TSX-V: DNAX) (OTC: BKKSF) has developed an innovative solution to the problem and already onboarded several high-profile users. Investors may want to keep a close eye on the stock over the coming quarters as it rolls out the platform.
For more information, visit the company’s website or download their investor presentation.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products.
Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including its CBD/THC cannabis formulations including ARLO CBD Beauty and InVibe® MD (“health & wellness” line), and secondly, its unique DermSafe® hand sanitizer; all made with its patented Invisicare® skin delivery technology.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
